1. Background {#sec108713}
=============

Caloric Restriction (CR), which is the reduction in calorie intake without inducing malnutrition ([@A22590R1]), is a well-known method for reducing weight, diminishing morbidity and mortality, and retarding aging ([@A22590R2]). Therefore, CR has been suggested as a robust nutritional intervention for fighting against obesity and extending lifespan ([@A22590R3]).

Although there are ample anecdotal proofs with regard to health benefits of caloric restriction and fasting in human, such dietary changes have recently received enthusiastic attention from scientists and undergone rigorous studies in laboratory animals and human subjects ([@A22590R4]).

In traditional Iranian medicine, inflammation has strong relationship with Imtila (food and blood accumulation in the body). Rhazes, Avicenna, and Haly Abbas described the Imtila as the accumulation of waste products in the body due to excess food, alcohol, and rest in addition to lack of exercise, which is, whether beneficial (Mahmooda) or Non-beneficial (Ghair-mahmooda) both would be toxic for the body. The accumulation of these waste products might lead to increase in blood volume, vessel wall tension, and vascular pressure ([@A22590R5]). Food restriction can help reducing this accumulation and accordingly reducing inflammation too.

Reduced generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS), deactivation of redox-sensitive transcription factors, and preventing the expression of clusters of inflammatory and oxidative stress genes are the most recent cutting-edge findings regarding possible beneficial effects of CR on diverse organisms ([@A22590R6]).

Modern studies have shown that energy metabolism and immune function are tightly interconnected through shared signaling mechanisms ([@A22590R7]).

Obesity, which is characterized by increased mass of adipose tissue, is accompanied with systemic inflammation. This simple link between obesity and inflammation justifies the influence of CR on systemic inflammation, immune response, and antioxidant defense ([@A22590R8]). Based on this connection, some investigators believe that CR acts through weight loss. In this model, CR-induced weight loss augments insulin sensitivity, reduces circulating inflammation-related products, and increases anti-inflammatory factors produced by adipocytes ([@A22590R9]). Reduced levels of serum interleukin (IL) IL-6, C-Reactive Protein (CRP) and Tumor Necrosis Factor (TNF)-α, suppress up-regulation of NuclearF (NF)-κB, cyclooxygenase-2 (COX-2), and inducible Nitric Oxide Synthase (iNOS) after CR-induced weight-loss, which have corroborated this hypothesis ([@A22590R10]). Many of the scientists, however, believe that the anti-inflammatory effect of CR is not limited to adipose tissue but is a systemic mechanism, affecting serum, liver, heart, hypothalamus, etc. ([@A22590R11]).

Similarity between rodents and humans in terms of association between CR and inflammation ([@A22590R12]) has enabled scientists to carry out studies in this regard on mice and rats instead of performing on humans.

It has been previously shown that CR protects laboratory rodents against a variety of inflammatory agents ([@A22590R13]). However, these reports are scant in the literature, particularly in terms of the effect of short-term CR strategies on inflammation. In addition, majority of available reports have focused only on laboratory changes and mechanisms.

2. Objectives {#sec108714}
=============

The objective of the present study is to examine short-term effects of a 30% reduction in daily calorie intake on both laboratory (CRP and ESR) and clinical (Perceptional) aspects of inflammation in a rat model. We did not find similar study about the effect of CR on clinical aspects like changes of paw edema.

3. Materials and Methods {#sec108719}
========================

3.1. Animals and Diets {#sec108715}
----------------------

A total of 23 male rats (*Rattus rattus*) 5-6 weeks old, and weighing 100 to 150 g were obtained from animal laboratory of Urmia University in Iran. The rats were housed individually in a temperature-controlled (20 - 22°C) room under 12 h : h light/dark cycles with free access to food and tap water for 6 - 7 weeks. After this acclimation period, at the age of 12 weeks, 18 rats were randomized into two equal and weight-matched groups: a control diet group (controls, n = 9) and a 30% CR diet group (cases, n = 9) by generating random numbers using standard software. Based on prior and similar studies about edema volume changes after formalin injection ([@A22590R14]), we decided to select 9 + 9 cases.

To determine daily requirement of food, more than enough food was placed in each case in the morning and the remaining was retrieved at night. The rats had ad libitum access to food in the interim. Accordingly, mean daily amount of required food was calculated (total food in the morning in g - remained food at night in g) as 15 g/rat. Thus, each rat in the case group had ad libitum access to 10.5 g food daily during the study period, while the control rats had free access to more than 15 g of food daily. Caloric restriction diets were adjusted to provide the same intake levels for total protein, minerals, and vitamins as in the control diet.

All conditions and handling of the animals were approved by the Ethics Committee of Shahed University (No. 41/168152) and conducted according to the Declaration of Helsinki.

3.2. Inducing Inflammation {#sec108716}
--------------------------

For anti-inflammatory activity, the formalin-induced edema model was used ([@A22590R15]). Rats were injected with 0.05 mL of 2.5 % formaldehyde solution into the sub-plantar region of the right hind paw. The paw volume was measured before and after formalin injection and the difference in these two volumes was used as an indication of inflammation. The paw volume was measured using a mercury-balance plethysmometer technique ([@A22590R16]).

Paw volume and body weight were recorded before injection, one hour after injection and then daily at a certain hour in all case and control rats for 8 consecutive days.

We measured paw volume and body weight twice by one observer daily.

3.3. Blood Sampling and Serum Parameters {#sec108717}
----------------------------------------

To determine baseline serum parameters, 5 rats were randomly selected and their blood samples (2 mL) were collected. In day 8, blood samples were obtained from all the study rats. Serum CRP, ESR, white blood cell count, red blood cell count, platelet count, and hemoglobin level were measured using conventional laboratory methods.

3.4. Statistical Analysis {#sec108718}
-------------------------

All results were expressed as means ± standard deviation, median (interquartile range), or frequency (%). Statistical analysis was conducted using SPSS statistical software (V 18.0). Distribution of the numerical data was tested using Kolmogorov-Smirnov test and QQ-plots. Differences were determined using Independent samples t test, repeated measures analysis, Mann-Whitney U test, or Fisher exact test, where appropriate. Significance was set at P \< 0.05.

4. Results {#sec108720}
==========

At baseline, case and control groups were comparable in terms of weight (250.11 ± 29.25 g vs. 252.22 ± 12.28 g, respectively); independent samples t test (P = 0.84) and paw volume (4.97 ± 0.67 mL vs. 4.56 ± 0.58 mL, respectively); and independent samples t test (P = 0.18) ([Tables 1](#tbl27872){ref-type="table"} and [2](#tbl27873){ref-type="table"}). Based on the result of repeated measures analysis, weight loss was significantly more prominent in cases than in controls during the study period (P \< 0.001) ([Figure 1](#fig20682){ref-type="fig"}). Percentage of weight change of the studied rats was significant too ([Table 3](#tbl27874){ref-type="table"}).

###### Mean Weight of the Studied rats in Different Occasions ^[a](#fn27022){ref-type="table-fn"},[b](#fn27023){ref-type="table-fn"}^

  Group         Baseline         Day 2            Day 3            Day 4            Day 5            Day 6            Day 7            Day 8
  ------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------
  **Case**      250.11 ± 29.25   243.11 ± 27.14   226.22 ± 25.23   225.22 ± 26.60   221.78 ± 27.16   220.56 ± 27.58   224.78 ± 27.82   227.67 ± 28.91
  **Control**   252.22 ± 12.28   246.56 ± 11.48   247.22 ± 12.13   249.11 ± 12.35   251.11 ± 12.65   251.89 ± 12.94   253.22 ± 12.35   253.22 ± 12.35

^a^ Data are presented as Mean ± Standard Deviation.

^b^ Values are presented as grams (g).

###### Mean Paw Volume of the Studied Rats in Different Occasions ^[a](#fn27024){ref-type="table-fn"},[b](#fn27025){ref-type="table-fn"}^

  Group         Baseline      Hour 1        Day 2         Day 3         Day 4         Day 5         Day 6         Day 7         Day 8
  ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------
  **Case**      4.97 ± 0.67   5.22 ± 0.66   6.17 ± 0.48   5.22 ± 0.54   4.92 ± 0.43   4.67 ± 0.44   4.42 ± 0.43   4.18 ± 0.40   3.95 ± 0.39
  **Control**   4.56 ± 0.58   4.77 ± 0.59   5.74 ± 0.78   5.63 ± 0.73   5.53 ± 0.74   5.45 ± 0.73   5.37 ± 0.73   5.31 ± 0.72   5.25 ± 0.71

^a^ Data are presented as Mean ± Standard Deviation.

^b^ Values are presented as milliliter (mL).

![Changes of Rat Weight on Different Occasions in the Study Groups](ircmj-17-07-22590-i001){#fig20682}

###### Percentage Change of Weight of the Studied Rats in Different Occasions ^[a](#fn27026){ref-type="table-fn"},[b](#fn27027){ref-type="table-fn"}^

  Group         Day 2                                           Day 3                                           Day 4                                           Day 5                                           Day 6                                           Day 7                                           Day 8
  ------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- -----------------------------------------------
  **Case**      -2.12 (0.30)                                    -9.40 (0.52)                                    -9.4 (0.63)                                     -11.10 (0.92)                                   -11.64 (0.33)                                   -9.45 (0.68)                                    -8.32 (0.77)
  **Control**   0.45 (1.10)                                     -2.11 (1.70)                                    -1.34 (1.12)                                    -0.54 (1.03)                                    -0.27 (1.12)                                    -0.01 (1.32)                                    0.12 (2.67)
  **P Value**   \< 0.001 ^[b](#fn27027){ref-type="table-fn"}^   \< 0.001 ^[b](#fn27027){ref-type="table-fn"}^   \< 0.001 ^[b](#fn27027){ref-type="table-fn"}^   \< 0.001 ^[b](#fn27027){ref-type="table-fn"}^   \< 0.001 ^[b](#fn27027){ref-type="table-fn"}^   \< 0.001 ^[b](#fn27027){ref-type="table-fn"}^   \< 0.001 ^[b](#fn27027){ref-type="table-fn"}^

^a^ Data are presented as median (interquartile range).

^b^ P Value \< 0.05 is statistically significant.

A trend similar to that for rat weight was also observed in this regard. Accordingly, mean paw volume decreased significantly and more saliently in the case group, particularly after day 3 (repeated measures analysis P = 0.001) ([Figure 2](#fig20683){ref-type="fig"}). Percentage change of paw edema was significant from the third day ([Table 4](#tbl27875){ref-type="table"}).

![Changes of Rat Paw Volume on Different Occasions in the Study Groups](ircmj-17-07-22590-i002){#fig20683}

###### Percentage Change of Mean Paw Volume of the Studied Rats in Different Occasions [a](#fn27028){ref-type="table-fn"}, [b](#fn27029){ref-type="table-fn"}

  Group         Hour 1        Day 2          Day 3                                           Day 4                                           Day 5                                           Day 6                                           Day 7                                           Day 8
  ------------- ------------- -------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- -----------------------------------------------
  **Case**      4.12 (0.80)   21.08 (6.12)   3.59 (7.29)                                     -0.12 (4.22)                                    -4.16 (7.01)                                    -9.98 (0.03)                                    -13.18 (0.28)                                   -16.87 (0.17)
  **Control**   3.33 (0.01)   21.45 (7.34)   20.04 (5.79)                                    19.24 (5.23)                                    17.23 (6.45)                                    16.22 (7.29)                                    14.12 (5.67)                                    12.01 (6.13)
  **P value**   0.18          0.39           \< 0.001 ^[b](#fn27029){ref-type="table-fn"}^   \< 0.001 ^[b](#fn27029){ref-type="table-fn"}^   \< 0.001 ^[b](#fn27029){ref-type="table-fn"}^   \< 0.001 ^[b](#fn27029){ref-type="table-fn"}^   \< 0.001 ^[b](#fn27029){ref-type="table-fn"}^   \< 0.001 ^[b](#fn27029){ref-type="table-fn"}^

^a^ Data are presented as median (interquartile range).

^b^ P value \< 0.05 is statistically significant.

Serum parameters of the studied rats at baseline and at endpoint are summarized in [Table 5](#tbl27876){ref-type="table"}. Between the two groups, however, only mean ESR was significantly higher in the control than in the case group at the endpoint (Independent samples t test, P = 0.001). While the frequency of cases with abnormal serum CRP was higher in controls than in cases on day 8, the difference did not reach a statistically significant level (Fisher exact test, P = 0.58). Other variables, including serum platelets, RBC and WBC numbers, and serum hemoglobin were not significantly different between the two groups on day 8.

###### Serum Parameters of Studied Rats at Baseline and at Endpoint ^[a](#fn27030){ref-type="table-fn"},[b](#fn27031){ref-type="table-fn"},[c](#fn27032){ref-type="table-fn"}^

  Serum parameters   CRP (+)    ESR            PLT                Hb               RBC            WBC
  ------------------ ---------- -------------- ------------------ ---------------- -------------- --------------
  **Baseline**       0 (0)      7.00 ± 1.75    2234.00 ± 558.50   56.50 ± 14.12    30.15 ± 7.53   28.50 ± 7.12
  **Endpoint**                                                                                    
  **Cases**          1 (11.1)   14.00 ± 1.55   5023.00 ± 558.11   132.60 ± 14.73   74.69 ± 8.30   58.80 ± 6.53
  **Controls**       3 (33.3)   29.00 ± 2.89   4963.22 ± 551.43   124.50 ± 13.83   70.01 ± 7.77   65.20 ± 7.24
  **P Value**        0.58       0.001 ^c^      0.38               0.42             0.59           0.19

^a^ Abbreviations: CRP, c-reactive protein; ESR, erythrocyte sedimentation rate (h); Hb, Hemoglobin (mg/dL); PLT, platelets (× 10^3^/μL); RBC, red blood cell (× 10^6^/μL); WBC, white blood cell (× 10^6^/μL).

^b^ Data are presented as frequency (%) or Mean ± standard Deviation.

^c^ P value (Case vs. controls) \< 0.05 is statistically significant.

5. Discussion {#sec108721}
=============

In the present study, we showed that a short-term, 30% reduction in daily calorie intake significantly hastened reversal of formalin-induced inflammation and serum ESR decline in rats. Acute and chronic inflammatory conditions are among the most important health problems all over the world. In many cases, the last choice is using medications such glucocorticoids and non-steroidal anti-inflammatory drugs. Many of these medications, however, are accompanied with serious complications and side-effects, particularly when they are used for a long time ([@A22590R17]). This is where traditional medicine may assist the modern medicine or even play a pivotal role.

Anti-inflammatory agents have been widely discussed in traditional Iranian medicine. *Arnebia euchroma* ([@A22590R16]), *Urtica pilulifera L.* seeds extracts ([@A22590R15]), *Berberis vulgaris L.* ([@A22590R18]), and *Anethum graveolens L.* ([@A22590R13]) are some available examples in the literature.

Although according to the published literature, evidence regarding CR and inflammation was first presented in 1930s by McCay et al. ([@A22590R19]), similar debates can be found in traditional Iranian medicine texts since a long time ago. "Food reduction" in the form of diminishing food quality, food quantity or both has been discussed as a way of dealing with inflammation ([@A22590R20]). We can describe this role by relating Imtila and inflammation in TIM references ([@A22590R5]).

Low-grade inflammation, as indicated by higher circulating levels of inflammatory mediators such as C-reactive protein, interleukin-6 and tumor necrosis factor-α, is a strong risk factor for several chronic diseases. There are data indicating that decreasing energy intake may be an effective therapy for reducing overall inflammation. Moreover, very-low-energy dietary weight loss reduces both circulating markers of inflammation and adipose-tissue cytokine production ([@A22590R21], [@A22590R22]).

Short-term dietary intervention resulted in reductions in proinflammatory cytokines and metabolic risk factors, including IL-6, IL-8 and TNF-α (45, 27, 28).

Beneficial effects of CR have been previously proposed in many health-related conditions such as aging, metabolic disorders, cancers, cardiovascular disease, and neurodegenerative disorders ([@A22590R23]).

Although some studies have shown that long- and mid-term CR may enhance immune functions through improving responses of T cells to mitogens, cytotoxic T lymphocyte activity, natural kill cell activity, and the capability of mononuclear cells in releasing pro-inflammatory cytokines and markers ([@A22590R1], [@A22590R24]), possible effects of short-term CR on immune system and inflammation are not clear.

We showed that short-term CR for only 8 days was significantly effective in alleviating of inflammation. At the same time, weight loss was significantly more prominent in case group compared to the control rats.

The simplest justification for the association between calorie intake and inflammation is based on the inflammatory changes in adiposity. As obesity is associated with the changes in number, distribution, and function of immune cells ([@A22590R25]) a low-grade inflammation is usually present in obese individuals and animals. On the other hand, CR in obesity has been associated with enhanced cell-mediated immune function and consequently, curtailed inflammatory responses ([@A22590R11], [@A22590R26], [@A22590R27]).

We also found that the number of rats with "positive" serum CRP was higher in the control than in case rats. However, this difference did not reach a statistically significant level. Small sample size may be the reason of this finding. Further studies with larger sample size and employment of quantitative, high sensitivity measurement of serum CRP are recommended in this regard.

According to some other reports, however, beneficial effects of CR against inflammation are not restricted to obese or over-weight cases ([@A22590R28]), indicating that decreased adiposity is possibly not the only mediator of these effects of CR. In line with this notion, some studies have shown that the protecting effect of CR against inflammation through reducing its markers such as CRP, IL-6 and plasminogen activator inhibitor type 1 is independent of obesity ([@A22590R29]). In some recent studies, CR favorably affected both innate and acquired immunities ([@A22590R30]). Other studies have reported that CR results in lower systemic inflammation ([@A22590R31]) with reduced inflammatory cytokine expression in various tissues ([@A22590R32]). Genomic profiling examinations in rodents have revealed that CR may also inhibit the release of pro-inflammatory mediators from macrophages ([@A22590R33]).

Enhanced T cell proliferation and IL-2 production, as well as decreased prostaglandin (PG) E2 production have been reported in CR experimental animals and humans ([@A22590R30], [@A22590R34]). It should be noted that PGE2 is a potent suppressor of T cell proliferation and IL-2 production and thus, a very potent lipid inflammatory mediator, which is involved in the pathogenesis of many inflammatory diseases ([@A22590R35]). In addition, it has been shown that in CR rats, the activity of cyclooxygenase (COX), a rate-limiting enzyme for eicosanoid synthesis, was lower compared to the control rats ([@A22590R36]).

Another possible mechanism that justifies the association between diet and inflammation is the role of orexigenic hormone, ghrelin. Dixit et al. showed that this hormone inhibits pro-inflammatory cytokine production by acting on various immune cell subsets ([@A22590R37]).

According to available data, it seems that the exact mechanism underlying anti-inflammatory effect of CR has not been exactly defined. Because of its complexity, it seems that CR exerts its anti-inflammatory role through multiple mechanisms. Based on a recent concept, energy accumulation in the body is the origin of chronic inflammation. According to this theory, energy expenditure induced by inflammatory response is a feedback to fight against energy surplus ([@A22590R38]).

Whatever the exact physiopathology of the association between CR and anti-inflammation, from a clinical viewpoint, its consequences are very important ([@A22590R39]). As, there is a solid connection between inflammation and many pathological conditions such as metabolic disease, type 2 diabetes, hypertension, atherosclerosis, fatty liver, cancer, asthma, etc. ([@A22590R22]), findings regarding the beneficial effects of CR on inflammation are critically important ([@A22590R40]).

In conclusion, this study showed that rats fed with a 30% calorie-restricted diet in comparison with ad libitum fed controls for 8 days had significantly more prominent regression of inflammation and this finding is reported for the first time in the literature. Small sample size and using conventional method of serum CRP measurement and one observer are limitations that are acknowledged.
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